Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Their discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 23, 2007 | Series B | $25M | 1 | — | — | Detail |
Nov 1, 2006 | Series A | $4M | 1 | — | — | Detail |
Aug 10, 2005 | Series A | $3M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | — | Series B |